Literature DB >> 9850172

p53 immunostaining as a significant adjunct diagnostic method for uterine surface carcinoma: precursor of uterine papillary serous carcinoma.

W Zheng1, R Khurana, S Farahmand, Y Wang, Z F Zhang, J C Felix.   

Abstract

Uterine papillary serous carcinoma (UPSC) is a biologically aggressive carcinoma that causes a disproportionate number of endometrial cancer deaths because of its dismal clinical outcome. Although the precursor lesion of UPSC has been suggested both morphologically and molecularly, diagnosis continues to represent a challenge to surgical pathologists, particularly in biopsy specimens, largely in part because of its multiple histologic patterns and many benign morphologic mimics. In this study, we used p53 immunohistochemical staining as an adjunct test to correctly identify six cases of uterine surface carcinoma (USC) prospectively and three cases retrospectively. Both sensitivity and specificity for this immunostaining method approached 100% when the cutoff score of p53 overexpression was 7 or higher. The precision estimated by receiving operating characteristic curve was 100%, indicating that the diagnostic value of the score for p53 overexpression was very high. p53 immunohistochemical staining was considered a significant adjunct diagnostic method for the probable precursor lesion of UPSC. The probable precursor lesion of UPSC, previously referred to as endometrial intraepithelial carcinoma or endometrial carcinoma in situ, appears to represent the early phase of UPSC. However, unlike its names would suggest, this lesion is often multicentric and behaves in a more aggressive fashion than regular in situ carcinomas. For this reason, we prefer the term uterine surface carcinoma, a term that is more descriptive and less restrictive, to emphasize the unique aggressive nature of the UPSC precursor lesion. The reason we postulate using the term uterine surface carcinoma rather than endometrial intraepithelial carcinoma or endometrial carcinoma in situ is that the latter terms would seem define a neoplastic process confined to the endometrial epithelium without potential for metastasis. In reality, the precursor lesion of UPSC has a tendency to stromal and vascular space involvement as seen by the presence of stromal and vascular invasion in one of the prospectively identified USC cases. Therefore, the term uterine surface carcinoma is selected to alert clinicians that this early carcinoma has features of carcinoma in situ, but still carries a potential for metastasis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9850172     DOI: 10.1097/00000478-199812000-00003

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  15 in total

1.  Endometrial serous carcinoma (uterine papillary serous carcinoma): precancerous lesions and the theoretical promise of a preventive approach.

Authors:  Oluwole Fadare; Wenxin Zheng
Journal:  Am J Cancer Res       Date:  2012-04-21       Impact factor: 6.166

Review 2.  Molecular pathogenesis of endometrial and ovarian cancer.

Authors:  Melissa A Merritt; Daniel W Cramer
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

3.  A case of minimal uterine serous carcinoma with distant lymph node metastasis without peritoneal dissemination.

Authors:  Kouichiro Kawano; Kimio Ushijima; Masato Yokomine; Akimasa Fukui; Morio Ijichi; Toshiharu Kamura
Journal:  J Gynecol Oncol       Date:  2011-03-31       Impact factor: 4.401

4.  Primary sources of pelvic serous cancer in patients with endometrial intraepithelial carcinoma.

Authors:  Lin Jia; Zeng Yuan; Yiying Wang; Janiel M Cragun; Beihua Kong; Wenxin Zheng
Journal:  Mod Pathol       Date:  2014-06-13       Impact factor: 7.842

5.  Nrf2 expression in endometrial serous carcinomas and its precancers.

Authors:  Ning Chen; Xiaofang Yi; Nisreen Abushahin; Shujie Pang; Donna Zhang; Beihua Kong; Wenxin Zheng
Journal:  Int J Clin Exp Pathol       Date:  2010-12-24

6.  Insights into endometrial serous carcinogenesis and progression.

Authors:  Oluwole Fadare; Wenxin Zheng
Journal:  Int J Clin Exp Pathol       Date:  2009-01-10

Review 7.  Intercepting pelvic cancer in the distal fallopian tube: theories and realities.

Authors:  Christopher P Crum
Journal:  Mol Oncol       Date:  2009-02-03       Impact factor: 6.603

8.  Molecular identification of "latent precancers" for endometrial serous carcinoma in benign-appearing endometrium.

Authors:  Xi Zhang; Sharon X Liang; Lin Jia; Ning Chen; Oluwole Fadare; Peter E Schwartz; Beihua Kong; Wenxin Zheng
Journal:  Am J Pathol       Date:  2009-05-12       Impact factor: 4.307

9.  Endometrial intraepithelial carcinoma in association with polyp: review of eight cases.

Authors:  Masanori Yasuda; Tomomi Katoh; Shinichi Hori; Kimiyoshi Suzuki; Kisaku Ohno; Masanori Maruyama; Naruaki Matsui; Sayuri Miyazaki; Naoki Ogane; Yoichi Kameda
Journal:  Diagn Pathol       Date:  2013-02-15       Impact factor: 2.644

10.  Endometrial Glandular Dysplasia (EmGD): morphologically and biologically distinctive putative precursor lesions of Type II endometrial cancers.

Authors:  Oluwole Fadare; Wenxin Zheng
Journal:  Diagn Pathol       Date:  2008-02-08       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.